We are each free to draw our own conclusions. I'm sure I'm not the only
one who would question objectivity when money from the
maunfacturer of a drug has been offered to and accepted by someone
involved in evaluating the safety of said drug.
As to falsification of data - I have read accounts of other researchers
who collected data that might have been cause for concerns about safety
being "silenced". Some may consider such claims ridiculous paranoia. I
consider them plausible, and not at all surprising whenever there are
potential profits to be made.
On Wed, 9 Feb 1994, Gary Banowetz wrote:
> Based upon your information, it appears that Dr. Bauman has done a
> considerable amount of work with BST and is highly qualified to present
> both his own data, and that of others. Are you suggesting that his data
> are inaccurate or have been falsified?
> Gary Banowetz